Organization: Health Canada
Year: 2024
Month: March
Request Number: A-2023-001148
Request Summary: Adverse Drug Reactions (ADRs) for Dexilant. Report numbers: 001062510. ADR for Ixazomib. Report number: E2B_06626740. ADR for Pantoprazole sodium. Report number: E2B_06587978. ADR for Tecta. Report number: 1055931. ADR for ADDERALL XR. Report number: 1068477. ADR for lanthanum. Report number: E2B_06642692. ADR for MEZAVANT. Report number: 1064965. ADRs for Lansoprazole. Report numbers: E2B_06627926, E2B_06624489, E2B_06628023.
Disposition: Disclosed in part
Number of pages: 544